This post may contain affiliate links. For educational purposes only — not medical advice. Details
Your LDL Went Up on Carnivore. Should You Panic?
You went carnivore, your energy climbed, your triglycerides dropped, your HDL looks great. Then your LDL cholesterol came back at 250, or 300, or higher, and your doctor's face went pale. I've been there with my own labs, and I've talked with a lot of people who feel that same jolt of fear.
So let's look honestly at what the actual research says. Not the hype, not the panic. The real studies, including one that got retracted, and why some very smart cardiologists still disagree.
What's a Lean Mass Hyper-Responder?
Some people on low-carb and carnivore diets see their LDL shoot way up. Researchers Nick Norwitz, Dave Feldman, and others gave this pattern a name: the Lean Mass Hyper-Responder, or LMHR.
The picture is pretty specific. It tends to show up in lean, active, metabolically healthy people. The classic markers are high LDL cholesterol, high HDL (the so-called "good" cholesterol), and low triglycerides. It's a very different situation from someone with high LDL plus obesity, high blood sugar, and high triglycerides.
The big question is simple to ask and hard to answer. In these lean folks, does the high LDL actually build plaque in their arteries? Or is it a different story than the standard warning suggests?
What the KETO Trial Actually Found
In 2024, cardiologist Dr. Matthew Budoff and colleagues published the KETO Trial in JACC: Advances. They took 80 people with diet-induced LDL of 190 or higher, high HDL, and low triglycerides. The average LDL was 272, and one person was as high as 591. On average they'd been low-carb for about 4.7 years.
The researchers matched these people one-to-one against folks from the Miami Heart study who had normal LDL, around 123 on average. Then they scanned everyone's arteries with coronary CT angiography, which is a detailed look at actual plaque.
Here's the part that grabbed headlines. There was no significant difference in coronary plaque between the high-LDL keto group and the normal-LDL comparison group. And within the keto group, the LDL number itself didn't correlate with how much plaque a person had.
That's genuinely interesting. If sky-high LDL always drove plaque in a simple, direct way, you'd expect to see it here. They didn't.
The Follow-Up Study, and an Important Twist
The same team ran a follow-up. They tracked 100 of these high-LDL individuals for one year with repeat artery scans to watch plaque change over time. In 2025 they published results arguing that existing plaque predicted new plaque, while ApoB and LDL did not.
I want to be straight with you about this one. In 2026, that follow-up paper was retracted at the request of the authors and the editors. The stated reason was methodology concerns that affected the reliability of the data. An expression of concern came first, then the full retraction.
So please don't lean on that one-year progression study as proof of anything. It's off the table now. This is exactly why I read the source instead of the headline, and why "the science says" deserves a second look.
Why Many Cardiologists Still Push Back Hard
Here's the other side, and it's a serious one. Mainstream lipidology holds that LDL and ApoB (the particle that carries cholesterol) causally drive atherosclerosis. That view rests on decades of data, genetic studies, and drug trials showing that lowering these particles lowers heart attacks.
Plenty of cardiologists look at the LMHR research and say: interesting, but not nearly enough. Their concerns are fair. The samples are small, dozens to a hundred people. The follow-up we had was only a year, and it got retracted. And critically, none of this measured hard outcomes like actual heart attacks, strokes, or deaths.
Plaque scans are a snapshot, not a lifetime. It's possible for a group to look fine at four or five years and still run into trouble at twenty. We just don't have that long-term data on LMHRs yet.
So Where Does That Leave You?
Honestly, in an open question. The KETO Trial suggests that high LDL in lean, metabolically healthy people may not behave the way the standard warning assumes. That's worth taking seriously, and it's worth researchers keeping at it. But "not what we assumed" is a long way from "definitely safe."
Here's what I've seen work as a reasonable middle path. Know your full picture, not just LDL. Ask your doctor about ApoB, Lp(a), a coronary artery calcium score, and your inflammatory markers. A calcium score especially can tell you whether you already have plaque, which matters far more than one cholesterol number in isolation.
And watch how the story unfolds. If a future high-quality, long-term study shows LMHRs building plaque faster, I'll tell you that too. Following the evidence means being willing to change your mind.
Please Read This Part
I'm not a doctor. I've researched this deeply and worked with a lot of people, but I'm not your doctor, and I've never seen your labs. Talk to a physician who knows your full medical picture before you make decisions about your own cholesterol.
This matters most if you have familial hypercholesterolemia (a genetic condition that keeps LDL very high) or existing heart disease. In those cases, high LDL is not something to treat casually, and the reassuring studies above were done in lean people without those conditions. If you take medications or have a diagnosed condition, any dietary change needs your doctor's input. Your situation might be different from the people in these studies, so get individual guidance.